Incyte (INCY) Research & Development (2010 - 2026)

Incyte (INCY) reported Research & Development of $515.9 million for Q1 2026, up 17.98% on a YoY basis from $437.3 million in Q1 2025, and up 2916.98% quarter-over-quarter from $17.1 million in Q4 2025.

Incyte (INCY) Research & Development (2010 - 2026) Analysis & Trends

Incyte has reported Research & Development for 17 years, with the latest figure at $515.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 17.98% year-over-year to $515.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 41.32% YoY), and the FY2025 full-year result was $2.1 billion, down 21.36% from the prior year.
  • Research & Development for Q1 2026 stood at $515.9 million, up from $17.1 million in the prior quarter.
  • The five-year high for Research & Development was $1.1 billion in Q2 2024, with the low at $17.1 million in Q4 2025.
  • Historically, Research & Development has averaged $458.4 million across 5 years, with a median of $437.3 million in 2025.
  • Annual changes were most pronounced in 2024 — Research & Development jumped 184.06% — and 2025, when it plunged 96.33%.
  • Incyte's Research & Development stood at $501.4 million in 2022, then dropped by 11.34% to $444.5 million in 2023, then grew by 4.85% to $466.0 million in 2024, then sank by 96.33% to $17.1 million in 2025, then jumped by 2916.98% to $515.9 million in 2026.
  • The last three Research & Development figures came in at $515.9 million (Q1 2026), $17.1 million (Q4 2025), and $506.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 515.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 515.90 Mn
Dec 31, 2025 17.10 Mn
Sep 30, 2025 506.58 Mn
Jun 30, 2025 494.92 Mn
Mar 31, 2025 437.28 Mn
Dec 31, 2024 466.03 Mn
Sep 30, 2024 573.17 Mn
Jun 30, 2024 1.14 Bn
Mar 31, 2024 429.26 Mn
Dec 31, 2023 444.49 Mn
Sep 30, 2023 375.71 Mn
Jun 30, 2023 400.75 Mn
Mar 31, 2023 406.64 Mn
Dec 31, 2022 501.36 Mn
Sep 30, 2022 384.01 Mn
Jun 30, 2022 347.20 Mn
Mar 31, 2022 353.37 Mn
Dec 31, 2021 472.83 Mn
Sep 30, 2021 334.95 Mn
Jun 30, 2021 343.51 Mn